What’s next for GLP-1s?
While GLP-1 drugs were first indicated as a treatment option for type 2 diabetes, recent clinical trials have looked at their use in resolving other issues related to obesity. As these expanded indications emerge, plan sponsors need better-defined strategies – ones that balance cost and utilization.
See what’s coming and how you can prepare.